A systematic exploration of the associations between amino acid variants and post-translational modifications

被引:0
|
作者
Qin, Gui-Min [1 ,2 ]
Hou, Yi-Bo [3 ]
Zhao, Xing-Ming [1 ]
机构
[1] Tongji Univ, Sch Elect & Informat Engn, Dept Comp Sci, Shanghai 201804, Peoples R China
[2] Xidian Univ, Sch Software, Xian 710126, Peoples R China
[3] Xidian Univ, Sch Comp Sci & Technol, Xian 710126, Peoples R China
基金
中国博士后科学基金;
关键词
Amino acid variants; Cross-talks; Diseases; Post-translational modifications; GENETIC POLYMORPHISMS; CROSS-TALK; PROTEIN; PHOSPHORYLATION; CANCER; DISEASE; ACETYLATION; APOPTOSIS; MUTATIONS; RESOURCE;
D O I
10.1016/j.neucom.2015.11.106
中图分类号
TP18 [人工智能理论];
学科分类号
081104 ; 0812 ; 0835 ; 1405 ;
摘要
The post-translational modifications (PTMs) are important to protein activities and play key roles in various kinds of biological processes. It has been well recognized that the alteration of PTMs may lead to diseases. However, it is still not clear how the PTMs are related to diseases. In this work, we systematically investigated the associations between PTM residues and disease related mutations. In particular, the common PTMs, including phosphorylation, ubiquitylation and acetylation, were considered here. By analyzing the PTM sites and the amino acid mutations, we found that the amino acid mutations co-occurring with PTM sites and PTM cross-talks tend to be deleterious mutations in diseases. Specifically, the deleterious single amino acid variants (SAVs) associated with cancer and muscular diseases tend to co-occur with phosphorylation residues. The PTM sites of proteins from nuclear envelope, protein complex and lysosome were found to be more likely adjacent to the deleterious amino acid variations. These findings provide insights into the associations between PTM5 and diseases, and can help identify novel disease genes in the future. (C) 2016 Elsevier B.V. All rights reserved.
引用
收藏
页码:13 / 18
页数:6
相关论文
共 50 条
  • [1] The exploration of amino acid variants co-occurring with post-translational modifications
    Qin Gui-Min
    Hou Yi-Bo
    Zhao Xing-Ming
    2015 34TH CHINESE CONTROL CONFERENCE (CCC), 2015, : 8531 - 8534
  • [2] Post-translational modifications in diabetic cardiomyopathy
    Li, Zhi
    Chen, Jie
    Huang, Hailong
    Zhan, Qianru
    Wang, Fengzhi
    Chen, Zihan
    Lu, Xinwei
    Sun, Guozhe
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2024, 28 (07)
  • [3] Post-translational modifications in neurodegeneration
    Didonna, Alessandro
    Benetti, Federico
    AIMS BIOPHYSICS, 2016, 3 (01): : 27 - 49
  • [4] Crosstalk between SUMOylation and other post-translational modifications in breast cancer
    Wei, Bajin
    Yang, Fan
    Yu, Luyang
    Qiu, Cong
    CELLULAR & MOLECULAR BIOLOGY LETTERS, 2024, 29 (01)
  • [5] Histone Variants and Their Post-Translational Modifications in Primary Human Fat Cells
    Jufvas, Asa
    Stralfors, Peter
    Vener, Alexander V.
    PLOS ONE, 2011, 6 (01):
  • [6] Yin and Yang in Post-Translational Modifications of Human D-Amino Acid Oxidase
    Sacchi, Silvia
    Rabattoni, Valentina
    Miceli, Matteo
    Pollegioni, Loredano
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2021, 8
  • [7] The evolution of post-translational modifications
    Bradley, David
    CURRENT OPINION IN GENETICS & DEVELOPMENT, 2022, 76
  • [8] Post-Translational Modifications and Diabetes
    Sharma, Chiranjeev
    Hamza, Abu
    Boyle, Emily
    Donu, Dickson
    Cen, Yana
    BIOMOLECULES, 2024, 14 (03)
  • [9] Simultaneous Affinity Enrichment of Two Post-Translational Modifications for Quantification and Site Localization
    Xie, Xueshu
    Shah, Samah
    Holtz, Anja
    Rose, Jacob
    Basisty, Nathan
    Schilling, Birgit
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2020, (156):
  • [10] Citrullination and the protein code: crosstalk between post-translational modifications in cancer
    Harada, Koyo
    Carr, Simon M.
    Shrestha, Amit
    La Thangue, Nicholas B.
    PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2023, 378 (1890)